GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hainan Poly Pharm Co Ltd (SZSE:300630) » Definitions » Pre-Tax Income

Hainan Poly Pharm Co (SZSE:300630) Pre-Tax Income : ¥379 Mil (TTM As of Sep. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Hainan Poly Pharm Co Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Hainan Poly Pharm Co's pretax income for the three months ended in Sep. 2023 was ¥133 Mil. Its pretax income for the trailing twelve months (TTM) ended in Sep. 2023 was ¥379 Mil. Hainan Poly Pharm Co's pretax margin was 25.63%.

During the past 11 years, Hainan Poly Pharm Co's highest Pretax Margin was 38.22%. The lowest was 21.20%. And the median was 31.85%.


Hainan Poly Pharm Co Pre-Tax Income Historical Data

The historical data trend for Hainan Poly Pharm Co's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hainan Poly Pharm Co Pre-Tax Income Chart

Hainan Poly Pharm Co Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 209.94 334.16 454.24 467.54 438.92

Hainan Poly Pharm Co Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 171.70 -31.96 139.51 138.60 132.83

Competitive Comparison of Hainan Poly Pharm Co's Pre-Tax Income

For the Drug Manufacturers - Specialty & Generic subindustry, Hainan Poly Pharm Co's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hainan Poly Pharm Co's Pre-Tax Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hainan Poly Pharm Co's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Hainan Poly Pharm Co's Pre-Tax Income falls into.



Hainan Poly Pharm Co Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Hainan Poly Pharm Co's Pretax Income for the fiscal year that ended in Dec. 2022 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=482.196+0+-40.152+4.927+-8.0540000000001
=439

Hainan Poly Pharm Co's Pretax Income for the quarter that ended in Sep. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=168.078+0+-12.26+-7.739+-15.247
=133

Pre-Tax Income for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥379 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hainan Poly Pharm Co  (SZSE:300630) Pre-Tax Income Explanation

Hainan Poly Pharm Co's Pretax Margin for the quarter that ended in Sep. 2023 is calculated as

Pretax Margin=Pretax Income/Revenue
=132.832/518.194
=25.63%

During the past 11 years, Hainan Poly Pharm Co's highest Pretax Margin was 38.22%. The lowest was 21.20%. And the median was 31.85%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hainan Poly Pharm Co Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Hainan Poly Pharm Co's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Hainan Poly Pharm Co (SZSE:300630) Business Description

Traded in Other Exchanges
N/A
Address
No.1509 Binsheng Road, 10th Floor, Zhejiang Province, Hangzhou, CHN, 310051
Hainan Poly Pharm Co Ltd is a pharmaceutical manufacturer in China. It manufactures injections, oral solid formulations, dry suspension, and other active pharmaceutical ingredients. The products offered by the company include Azithromycin for Injection, Ganciclovir Sodium for Injection. Octreotide Acetate Injection, Trimebutine Maleate tablets, Desloratadine, Trimebutine Maleate, and GANCICLOVIR among others.
Executives
Fan De Zhu Independent director
Xie Hui Fang Supervisors
Pu Jian Executives
Xu Zhao Securities Affairs Representative
Shen Shi Hua Executives
Zhou Mao Directors, Directors, and Executives

Hainan Poly Pharm Co (SZSE:300630) Headlines

No Headlines